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Aim. Coronary artery bypass grafting (CABG) and tricuspid valve replacement (tVR) are available therapeutic options for cardiac 
allograft vasculopathy (CAV) and tricuspid regurgitation (tR), respectively after orthotopic heart transplantation (oHt). to our knowledge, 
these two procedures have never been reported simultaneously in a heart transplant recipient in the literature.
Materials and methods. We present the first incidence of a simultaneous CABG and tVR with a BiocortMbioprosthetic valve in 
a heart transplant recipient 25 years after the original transplant operation, the longest reported duration before reoperation after oHt.
Results. Early postoperative course was complicated by complete heart block requiring placement of dual chamber pacemaker. 
Patient progressed well after this intervention and was eventually discharged to home and remained asymptomatic on follow-up. 
Conclusion. Concomitatnt CAV and tVR for severe tR is a safe and effective treatment option with low perioperative mortality and 
favorable short and long term outcomes in heart transplant recipients. 
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We present a patient who successfully underwent 
coronary artery bypass grafting (CABG) and tricus-
pid valve replacement (TVR) 25 years after ortho-
topic heart transplantation (OHT). To our knowledge, 
this is the longest period of time since OHT for a pa-
tient to undergo both procedures concomitantly.
A 67 year old male who underwent OHT 25 years 
ago for ischemic cardiomyopathy, with last endomyo-
cardial biopsy 20 years ago and no prior prophylactic 
tricuspid valve annuloplasty, presented with wors-
ening generalized fatigue, dyspnea on exertion, and 
palpitations. Electrocardiogram showed new atrial fi-
brillation with controlled ventricular response. Echo-
cardiogram showed left ventricular ejection fraction 
of 50–55 %, moderately reduced right ventricular 
function, and severe tricuspid regurgitation with a 
flail anterior leaflet. Coronary angiogram showed 
subtotal distal left main stenosis with moderate cir-
cumflex stenosis. Patient was taken to the operating 
room for a combined CABG and TVR. He was placed 
on cardiopulmonary bypass (CPB) using axillary – 
femoral cannulation and a redo median sternotomy 
was performed. Left internal thoracic artery and sa-
phenous vein were used to bypass the LAD and OM, 
respectively. Tricuspid valve was accessed via right 
atriotomy and replaced with a 33-mm BiocorTMbio-
prosthetic valve (St.Jude Medical Inc.). He was suc-
cessfully weaned off CPB in normal sinus rhythm. 
Post-operative course was complicated by devel-
opment of complete heart block on post-operative 
day (POD) 3 that required placement of a permanent 
pacemaker. He progressed well and was discharged 
home on POD 17. Upon follow up, on POD 31, he 
had good energy and no complaints of dyspnea.
Discussion
Due to advances in immunosuppression therapy, 
long-term survival after OHT remains excellent, 
with 10- and 20-year survival rates reported to be 
64 % and 56 %, respectively [1]. CAV, with an inci-
dence of more than 50 % by 10 years [2], accounts 
for major long-term morbidity and mortality among 
heart transplant recipients. It represents a constella-
tion of vascular changes characterized by fibromus-
cular intimal hyperplasia, atherosclerosis, vasculitis, 
or any combination of the three. The most common 
type of lesion is fibromuscular intimal hyperpla-
sia, which tends to be circumferential and involves 
large and small epicardial coronary arteries, as well 
as intramyocardial branches. Atherosclerosis, by 
contrast, tends to be eccentric and generally oc-
curs proximally, sparing the intramyocardial arter-
ies. Evidence for atherosclerosis as a manifestation 
of CAV comes from the fact that the pediatric heart 
transplant recipients have also been found to have 
atheromas [3]. In adults with longer graft survival 
there may be both focal atherosclerotic disease as 
well as diffuse fibromuscular intimal hyperplasia 
[4], and this was the likely manifestation of CAV in 
this patient.
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Between 2 to 5.8 % of heart transplant recipients 
develop severe tricuspid regurgitation that is symp-
tomatic and refractory to medical management. It 
is most commonly secondary to flail leaflets from 
chordal damage sustained during endomyocardial bi-
opsies [5], and the mean time from heart transplanta-
tion to diagnosis of severe TR has been reported to 
be 43 months [6]. This patient first developed severe 
TR from a flail leaflet 25 years after transplantation 
and 20 years from last endomyocardial biopsy, a first 
in current literature.CAV and valvular disease, espe-
cially tricuspid regurgitation (TR) due to repeated 
endomyocardial biopsies, contribute in large part to 
late morbidity after OHT. CABG and TVR are avail-
able therapeutic options[7] but there is very little data 
in current literature regarding operative intervention 
more than 10 years after OHT. There is even less data 
regarding combined CABG and TVR.
Bhama et. al reported a series of 13 patients who 
underwent CABG 12.3 +/- 6.3 years after OHT with 
no perioperative mortality and a 92 % 1-year survival 
rate [8]. Raghavan et. al prospectively reviewed 9 pa-
tients who underwent TVR 12 +/- 3.2 years after OHT 
and reported only one death over a period of 6 months 
[9].Goerler et. al reported a series of 44 patients who 
underwent 19 CABGs 9.0 +/- 5.5 years after OHT, 
and 20 tricuspid valve procedures 8.6 +/- 4.2 years 
after OHT. Early mortality in this series was 4.5 % 
and 1-year survival was reported to be 84 %. Two 
patients in this series underwent concomitant CABG 
and tricuspid valve procedures [2]. Musci et. al re-
ported one case of a patient who underwent CABG 
and TVR 10.7 years after OHT with no perioperative 
or short-term mortality [10].
Our patient underwent combined CABG and TVR 
25 years after OHT, a much longer interval than what 
has previously been reported. We have shown this 
procedure can be safely performed with good periop-
erative outcome.
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Figure 2. Non-contrast CT Angiograpahy showing calcification 
and stenosis of Left Anterior Descending (LAD) artery
